Evidence map›Paper›PMID 41104346›Full record

ReviewEuropean heart journal. Imaging methods and practice2025

The changing landscape of multimodality imaging in congenital heart disease: white paper.

G Di Salvo, J Sabatino, S V Babu-Narayan, A Arvanitaki, B Bonello, A Van De Bruaene, M Cantinotti, L Dos Subira, F Raimondi, T Bharucha and 11 more

Abstract readReview
In one paragraph

Review in European heart journal. Imaging methods and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Unveiling ccTGA complexity: CMR and 3D modelling for surgical planning-a case series.European heart journal. Imaging methods and practice · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

G Di SalvoDepartment of Women's and Children's Health, Pediatric Cardiology and Adult Congenital Heart Disease, University of Padua, Via Giustiniani, Padova 3 - 35128, Italy.ORCID https://orcid.org/0000-0002-0305-0113
J SabatinoDepartment of Women's and Children's Health, Pediatric Cardiology and Adult Congenital Heart Disease, University of Padua, Via Giustiniani, Padova 3 - 35128, Italy.
S V Babu-NarayanDepartment of Adult Congenital Heart Disease, Royal Brompton Hospital, London, United Kingdom.
A ArvanitakiAdult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guy's and St Thomas's NHS Foundation Trust, Imperial College, London, United Kingdom.
B BonelloPediatric Cardiology, Great Ormond Street Hospital, Great Ormond street, London WC1N 3JH, UK.
A Van De BruaeneCongenital Cardiology, University Hospitals Leuven, Leuven, Belgium.
M CantinottiDepartment of Pediatric Cardiology and GUCH Unit, Fondazione CNR Regione Toscana G Monasterio, Pisa, Italy.
L Dos SubiraAdult Congenital Heart Disease Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
F RaimondiPediatric and Adult Congenital Heart Disease, pope Giovanni XXIII Hospital, Bergamo, Italy.
T BharuchaDepartment of Paediatric Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
R EnachePediatric Cardiology Department, Prof. Dr. C.C. Iliescu Emergency Institute for Cardiovascular Diseases, Bucharest, Romania.
G GreilDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
H LatusPediatric Heart Center, University Children's Hospital, Feulgenstrasse 12, Giessen D-35392, Germany.ORCID https://orcid.org/0000-0003-3939-6025
M BhatDepartment of Pediatric Cardiology, Pediatric Heart Center, Avd 67 Skåne University Hospital in Lund, Lund SE-221-85, Sweden.
E ValsangiacomoDivision of Pediatric Cardiology, University Children's Hospital, Steinwiesstrasse 75, Zurich 8032, Switzerland.
B CosynsDepartment of Cardiology, CHVZ (Centrum Voor Hart en Vaatziekten), Universitair Ziekenhuis, 101 Laarbeeklaan, B Brussels, Belgium.
S E PetersenWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University London, Charterhouse Square, London EC1M 6BQ, UK.ORCID https://orcid.org/0000-0003-4622-5160
V DelgadoCardiology, Hospital University Germans Trias i Pujol, Badalona, Spain.
H GrotenhuisDepartment of Pediatric Cardiology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
M BridaAdult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton & Harefield Hospitals, Guys & St Thomas's NHS Trust and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.ORCID https://orcid.org/0000-0001-8754-8156
Jolien W Roos-HesselinkDepartment of Cardiology, Thorax Centre, Erasmus Medical Centre, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-8101-5954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The congenital heart disease (CHD) population has seen substantial growth due to advancements in paediatric cardiac care, cardiothoracic surgery, anaesthesia, and intensive care. Although improved surgical interventions have enhanced survival rates for even the most severe defects, such as hypoplastic left heart syndrome, most CHD patients remain palliated rather than cured, requiring lifelong expert care. With increasing survival, new challenges emerge in managing the ageing CHD population, particularly regarding changing medical, psychosocial needs, and the evolving epidemiology of CHD. Imaging plays a pivotal role in CHD care, offering precise anatomical and physiological insights necessary for effective management and risk stratification. The European Association of Cardiovascular Imaging (EACVI) established a shared interest group (SIG) to improve imaging standardization, promote education, and foster research for CHD patients. Multimodality imaging, including echocardiography, cardiovascular magnetic resonance (CMR), and computed tomography (CT), is critical in guiding interventions and improving outcomes. The SIG also addresses gaps in education, research, and global healthcare disparities, ensuring a collaborative and systematic approach to CHD care. Advances in imaging technology, genetic research, and tissue engineering hold promise for further improving the longevity and quality of life for CHD patients in the future.

Indexed as

congenital heart diseaselife-long caremultimodality imaging

Identifiers

PMID41104346
PMCPMC12527343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.